![Fredrick D. Cobb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Fredrick D. Cobb
Anciens postes connus de Fredrick D. Cobb
Sociétés | Poste | Début | Fin |
---|---|---|---|
AYALA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 06/11/2009 | - |
Directeur Financier/CFO | 06/11/2009 | - | |
Metaphore Pharmaceuticals, Inc.
![]() Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Comptroller/Controller/Auditor | - | - |
Formation de Fredrick D. Cobb
Seton Hall University | Graduate Degree |
Cornell University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Metaphore Pharmaceuticals, Inc.
![]() Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Health Technology |
Advaxis, Inc.
![]() Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Bourse
- Insiders
- Fredrick D. Cobb
- Expérience